E2B Standard as Acceptable Method of Reporting SAEs Occurring During Clinical Trial Conduct to SAHPRA

Home > E2B Standard as Acceptable Method of Reporting SAEs Occurring During Clinical Trial Conduct to SAHPRA

01 Apr E2B Standard as Acceptable Method of Reporting SAEs Occurring During Clinical Trial Conduct to SAHPRA

Posted at 16:02h in by

This document is intended to provide communication to various stakeholders conducting Clinical Trials on allowed method for  Serious Aderse Events (SAE) reporting to SAHPRA.

Download latest version
Document Number: CT06-2025/26
Version: 1
Date Updated: 01/04/2026
File Type: www
Category: Communication to industry
Unit: Clinical Evaluations Management, Clinical Trials